Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Biol Res ; 55(1): 26, 2022 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-35962402

RESUMO

BACKGROUND: Unsubstantiated concerns have been raised on the potential correlation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infertility, leading to vaccine hesitancy in reproductive-aged population. Herein, we aim to evaluate the impact of inactivated SARS-CoV-2 vaccination on embryo ploidy, which is a critical indicator for embryo quality and pregnancy chance. METHODS: This was a retrospective cohort study of 133 patients who underwent preimplantation genetic testing for aneuploidy (PGT-A) cycles with next-generation sequencing technology from June 1st 2021 to March 17th 2022 at a tertiary-care medical center in China. Women fully vaccinated with two doses of Sinopharm or Sinovac inactivated vaccines (n = 66) were compared with unvaccinated women (n = 67). The primary outcome was the euploidy rate per cycle. Multivariate linear and logistic regression analyses were performed to adjust for potential confounders. RESULTS: The euploidy rate was similar between vaccinated and unvaccinated groups (23.2 ± 24.6% vs. 22.6 ± 25.9%, P = 0.768), with an adjusted ß of 0.01 (95% confidence interval [CI]: -0.08-0.10). After frozen-thawed single euploid blastocyst transfer, the two groups were also comparable in clinical pregnancy rate (75.0% vs. 60.0%, P = 0.289), with an adjusted odds ratio of 6.21 (95% CI: 0.76-50.88). No significant associations were observed between vaccination and cycle characteristics or other laboratory and pregnancy outcomes. CONCLUSIONS: Inactivated SARS-CoV-2 vaccination had no detrimental impact on embryo ploidy during in vitro fertilization treatment. Our finding provides further reassurance for vaccinated women who are planning to conceive. Future prospective cohort studies with larger datasets and longer follow-up are needed to confirm the conclusion.


Assuntos
COVID-19 , Diagnóstico Pré-Implantação , Adulto , Aneuploidia , Blastocisto , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Feminino , Fertilização in vitro , Testes Genéticos , Humanos , Ploidias , Gravidez , Taxa de Gravidez , Estudos Prospectivos , Estudos Retrospectivos , SARS-CoV-2 , Vacinação
2.
Environ Sci Pollut Res Int ; 29(1): 543-552, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34331646

RESUMO

There is a rising concern that air pollution plays an important role in the COVID-19 pandemic. However, the results were not consistent on the association between air pollution and the spread of COVID-19. In the study, air pollution data and the confirmed cases of COVID-19 were both gathered from five severe cities across three countries in South America. Daily real-time population regeneration (Rt) was calculated to assess the spread of COVID-19. Two frequently used models, generalized additive models (GAM) and multiple linear regression, were both used to explore the impact of environmental pollutants on the epidemic. Wide ranges of all six air pollutants were detected across the five cities. Spearman's correlation analysis confirmed the positive correlation within six pollutants. Rt value showed a gradual decline in all the five cities. Further analysis showed that the association between air pollution and COVID-19 varied across five cities. According to our research results, even for the same region, varied models gave inconsistent results. For example, in Sao Paulo, both models show SO2 and O3 are significant independent variables, however, the GAM model shows that PM10 has a nonlinear negative correlation with Rt, while PM10 has no significant correlation in the multiple linear model. Moreover, in the case of multiple regions, currently used models should be selected according to local conditions. Our results indicate that there is a significant relationship between air pollution and COVID-19 infection, which will help states, health practitioners, and policy makers in combating the COVID-19 pandemic in South America.


Assuntos
Poluentes Atmosféricos , Poluição do Ar , COVID-19 , Poluentes Atmosféricos/análise , Poluição do Ar/análise , Brasil , Cidades , Humanos , Pandemias , Material Particulado/análise , SARS-CoV-2
3.
Biol. Res ; 55: 26-26, 2022. tab
Artigo em Inglês | LILACS | ID: biblio-1447502

RESUMO

BACKGROUND: Unsubstantiated concerns have been raised on the potential correlation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infertility, leading to vaccine hesitancy in reproductive-aged population. Herein, we aim to evaluate the impact of inactivated SARS-CoV-2 vaccination on embryo ploidy, which is a critical indicator for embryo quality and pregnancy chance. METHODS: This was a retrospective cohort study of 133 patients who underwent preimplantation genetic testing for aneuploidy (PGT-A) cycles with next-generation sequencing technology from June 1st 2021 to March 17th 2022 at a tertiary-care medical center in China. Women fully vaccinated with two doses of Sinopharm or Sinovac inactivated vaccines (n = 66) were compared with unvaccinated women (n = 67). The primary outcome was the euploidy rate per cycle. Multivariate linear and logistic regression analyses were performed to adjust for potential confounders. RESULTS: The euploidy rate was similar between vaccinated and unvaccinated groups (23.2 ± 24.6% vs. 22.6 ± 25.9%, P = 0.768), with an adjusted ß of 0.01 (95% confidence interval [CI]: -0.08-0.10). After frozen-thawed single euploid blastocyst transfer, the two groups were also comparable in clinical pregnancy rate (75.0% vs. 60.0%, P = 0.289), with an adjusted odds ratio of 6.21 (95% CI: 0.76-50.88). No significant associations were observed between vaccination and cycle characteristics or other laboratory and pregnancy outcomes. CONCLUSIONS: Inactivated SARS-CoV-2 vaccination had no detrimental impact on embryo ploidy during in vitro fertilization treatment. Our finding provides further reassurance for vaccinated women who are planning to conceive. Future prospective cohort studies with larger datasets and longer follow-up are needed to confirm the conclusion.


Assuntos
Humanos , Feminino , Gravidez , Adulto , Diagnóstico Pré-Implantação , COVID-19/prevenção & controle , Ploidias , Blastocisto , Fertilização in vitro , Testes Genéticos , Estudos Prospectivos , Estudos Retrospectivos , Vacinação , Taxa de Gravidez , Vacinas contra COVID-19 , SARS-CoV-2 , Aneuploidia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA